381 related articles for article (PubMed ID: 37599566)
21. Current global status of male reproductive health.
De Jonge CJ; Barratt CLR; Aitken RJ; Anderson RA; Baker P; Chan DYL; Connolly MP; Eisenberg ML; Garrido N; Jørgensen N; Kimmins S; Krausz C; McLachlan RI; Niederberger C; O'Bryan MK; Pacey A; Priskorn L; Rautakallio-Hokkanen S; Serour G; Veltman JA; Vogel DL; Vazquez-Levin MH
Hum Reprod Open; 2024; 2024(2):hoae017. PubMed ID: 38699533
[TBL] [Abstract][Full Text] [Related]
22. ESHRE guideline: recurrent pregnancy loss.
; Bender Atik R; Christiansen OB; Elson J; Kolte AM; Lewis S; Middeldorp S; Nelen W; Peramo B; Quenby S; Vermeulen N; Goddijn M
Hum Reprod Open; 2018; 2018(2):hoy004. PubMed ID: 31486805
[TBL] [Abstract][Full Text] [Related]
23. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study.
Koedooder R; Singer M; Schoenmakers S; Savelkoul PHM; Morré SA; de Jonge JD; Poort L; Cuypers WJSS; Beckers NGM; Broekmans FJM; Cohlen BJ; den Hartog JE; Fleischer K; Lambalk CB; Smeenk JMJS; Budding AE; Laven JSE
Hum Reprod; 2019 Jun; 34(6):1042-1054. PubMed ID: 31119299
[TBL] [Abstract][Full Text] [Related]
24. No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis.
Katalinic A; Noftz MR; Garcia-Velasco JA; Shulman LP; van den Anker JN; Strauss Iii JF
Hum Reprod Open; 2024; 2024(1):hoae004. PubMed ID: 38344249
[TBL] [Abstract][Full Text] [Related]
25. Does luteal phase progesterone supplementation affect physical and psychosocial well-being among women undergoing modified natural cycle-FET? A sub-study of a randomized controlled trial.
Colombo C; Pistoljevic-Kristiansen N; Saupstad M; Bergenheim SJ; Spangmose AL; Klajnbard A; la Cour Freiesleben N; Løkkegaard EC; Englund AL; Husth M; Breth Knudsen U; Alsbjerg B; Prætorius L; Løssl K; Schmidt L; Pinborg A
Hum Reprod; 2023 Oct; 38(10):1970-1980. PubMed ID: 37634089
[TBL] [Abstract][Full Text] [Related]
26. Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3).
Donnez J; Becker C; Taylor H; Carmona Herrera F; Donnez O; Horne A; Paszkowski M; Petraglia F; Renner SP; Patel A; Boolell M; Bestel E; Dolmans MM
Hum Reprod; 2024 Jun; 39(6):1208-1221. PubMed ID: 38648863
[TBL] [Abstract][Full Text] [Related]
27. Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials.
Humaidan P; Nelson SM; Devroey P; Coddington CC; Schwartz LB; Gordon K; Frattarelli JL; Tarlatzis BC; Fatemi HM; Lutjen P; Stegmann BJ
Hum Reprod; 2016 Sep; 31(9):1997-2004. PubMed ID: 27343272
[TBL] [Abstract][Full Text] [Related]
28. The Maribor consensus: report of an expert meeting on the development of performance indicators for clinical practice in ART.
; Vlaisavljevic V; Apter S; Capalbo A; D'Angelo A; Gianaroli L; Griesinger G; Kolibianakis EM; Lainas G; Mardesic T; Motrenko T; Pelkonen S; Romualdi D; Vermeulen N; Tilleman K
Hum Reprod Open; 2021; 2021(3):hoab022. PubMed ID: 34250273
[TBL] [Abstract][Full Text] [Related]
29. Population-wide contribution of medically assisted reproductive technologies to overall births in Australia: temporal trends and parental characteristics.
Choi SKY; Venetis C; Ledger W; Havard A; Harris K; Norman RJ; Jorm LR; Chambers GM
Hum Reprod; 2022 May; 37(5):1047-1058. PubMed ID: 35220435
[TBL] [Abstract][Full Text] [Related]
30. An international terminology for endometriosis, 2021
; Tomassetti C; Johnson NP; Petrozza J; Abrao MS; Einarsson JI; Horne AW; Lee TTM; Missmer S; Vermeulen N; Zondervan KT; Grimbizis G; De Wilde RL
Hum Reprod Open; 2021; 2021(4):hoab029. PubMed ID: 34693033
[TBL] [Abstract][Full Text] [Related]
31. Does dual oocyte retrieval with continuous FSH administration increase the number of mature oocytes in low responders? An open-label randomized controlled trial.
Boudry L; Mateizel I; Wouters K; Papaleo E; Mackens S; De Vos M; Racca A; Adriaenssens T; Tournaye H; Blockeel C
Hum Reprod; 2024 Mar; 39(3):538-547. PubMed ID: 38199789
[TBL] [Abstract][Full Text] [Related]
32. Serum progesterone is lower in ovarian stimulation with highly purified HMG compared to recombinant FSH owing to a different regulation of follicular steroidogenesis: a randomized controlled trial.
Bosch E; Alamá P; Romero JL; Marí M; Labarta E; Pellicer A
Hum Reprod; 2024 Feb; 39(2):393-402. PubMed ID: 38037188
[TBL] [Abstract][Full Text] [Related]
33. Androgen and inhibin B levels during ovarian stimulation before and after 8 weeks of low-dose hCG priming in women with low ovarian reserve.
Friis Wang N; Bogstad JW; Petersen MR; Pinborg A; Yding Andersen C; Løssl K
Hum Reprod; 2023 Sep; 38(9):1807-1815. PubMed ID: 37354554
[TBL] [Abstract][Full Text] [Related]
34. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial.
Griesinger G; Blockeel C; Sukhikh GT; Patki A; Dhorepatil B; Yang DZ; Chen ZJ; Kahler E; Pexman-Fieth C; Tournaye H
Hum Reprod; 2018 Dec; 33(12):2212-2221. PubMed ID: 30304457
[TBL] [Abstract][Full Text] [Related]
35. Birthweight and other perinatal outcomes of singletons conceived after assisted reproduction compared to natural conceived singletons in couples with unexplained subfertility: follow-up of two randomized clinical trials.
Wessel JA; Mol F; Danhof NA; Bensdorp AJ; Tjon-Kon Fat RI; Broekmans FJM; Hoek A; Mol BWJ; Mochtar MH; van Wely M;
Hum Reprod; 2021 Feb; 36(3):817-825. PubMed ID: 33347597
[TBL] [Abstract][Full Text] [Related]
36. Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition.
Hidalgo-Mazzei D; Berk M; Cipriani A; Cleare AJ; Florio AD; Dietch D; Geddes JR; Goodwin GM; Grunze H; Hayes JF; Jones I; Kasper S; Macritchie K; McAllister-Williams RH; Morriss R; Nayrouz S; Pappa S; Soares JC; Smith DJ; Suppes T; Talbot P; Vieta E; Watson S; Yatham LN; Young AH; Stokes PRA
Br J Psychiatry; 2019 Jan; 214(1):27-35. PubMed ID: 30520709
[TBL] [Abstract][Full Text] [Related]
37. Eight weeks of androgen priming by daily low-dose hCG injections before ICSI treatment in women with low ovarian reserve.
Friis Wang N; Bogstad JW; Pors SE; Petersen MR; Pinborg A; Yding Andersen C; Løssl K
Hum Reprod; 2023 Apr; 38(4):716-725. PubMed ID: 36721920
[TBL] [Abstract][Full Text] [Related]
38. Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial.
Hamdine O; Macklon NS; Eijkemans MJ; Laven JS; Cohlen BJ; Verhoeff A; van Dop PA; Bernardus RE; Lambalk CB; Oosterhuis GJ; Holleboom CA; van den Dool-Maasland GC; Verburg HJ; van der Heijden PF; Blankhart A; Fauser BC; Broekmans FJ;
Hum Reprod; 2013 Dec; 28(12):3227-35. PubMed ID: 24129613
[TBL] [Abstract][Full Text] [Related]
39. Cumulative live birth rates in low-prognosis women.
Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; van Golde RJT; Hoek A; Lambalk CB; de Bruin JP; Fleischer K; Mochtar MH; Kuchenbecker WKH; Laven JSE; Mol BWJ; Torrance HL; Broekmans FJM;
Hum Reprod; 2019 Jun; 34(6):1030-1041. PubMed ID: 31125412
[TBL] [Abstract][Full Text] [Related]
40. Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients.
Esteves SC; Yarali H; Vuong LN; Carvalho JF; Özbek İY; Polat M; Le HL; Pham TD; Ho TM; Humaidan P; Alviggi C
Hum Reprod; 2021 Jul; 36(8):2157-2169. PubMed ID: 34179973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
